Summary
Experimental heterotopic bone formation was produced by subcutaneous implants of demineralized allogeneic bone matrix (DABM) in vitamin D-deficient (−D) animals that were either not treated or given vitamin D3 (+D) or 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to determine the role of vitamin D and its most active metabolite in osteoinduction and implant remodeling. Histologically, implants in both +D and −D groups caused a similar acute inflammatory response, formation of a fibrous capsule, and chondrogenesis by 1 to 2 weeks after implantation. However, by 3 weeks after implantation implants in the −D animals had formed less bone matrix, had developed a defect in matrix mineralization, had reduced bone forming and bone resorbing surfaces, and had altered bone architecture resulting from defective bone remodeling. The altered histology in −D animals was not corrected by 10 weeks after implantation. Treatment of vitamin D-deficient rats with 1,25(OH)2D3, 65 pmol/day for 3 weeks, corrected both the defect in mineralization and the abnormal histology. The results indicate that (1) vitamin D deficiency does not alter either the timing or the sequence of histologic events associated with osteoinduction but dramatically reduces the magnitude of the response, (2) vitamin D deficiency not only impairs mineralization but also reduces bone formation and resorption, and (3) 1,25(OH)2D3 mimics all of the actions of vitamin D with regard to correcting the abnormal osteoinductive response and bone histomorphometry.
Similar content being viewed by others
References
Urist MR (1965) Bone formation by autoinduction. Science 150:893–899
Reddi AH, Huggins CB (1972) Biochemical sequences in transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci (USA) 69:1601–1605
Vandersteenhoven JJ, Spector M (1983) Osteoinduction within porous polysulfone implants at heterotopic sites using demineralized allogeneic bone matrix. J Biomed Mat Res 17:793–806
Reddi AH (1985) Regulation of bone differentiation by local and systemic factors. In: Peck WA (ed) Bone and Mineral Research. Elsevier, New York, pp 27–47
Urist MR (1979) Bone morphodifferentiation and tumorigenesis. Perspect Biol Med 22:S89–113
Urist MR, Granstein R, Nogami H, Avenson L, Murphy R (1977) Transmembrane bone morphogenesis across multiwalled diffusion chambers. Arch Surg 112:612–619
Baylink DJ, Morey ER, Ivey JL, Stauffer M (1980) In: Norman AW (ed) Vitamin D: molecular biology and clinical nutrition. Marcel Dekker, Inc. New York
Sampath TK, Wientraub S, Reddi AH (1984) Extracellular matrix proteins involved in bone induction are vitamin D dependent. Biochem Biophys Res Comm 124:829–835
Lambert PW, DeOreo PB, Hollis BW, Fu IY, Ginsberg BJ, Roos BA (1981) Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects. J Lab Clin Med 98:536–548
Urist MR, Earnest F, Kimball KM, DiJulio TP, Iwata H (1974) Bone morphogenesis in implants of residues of radio-isotope-labelled bone matrix. Calcif Tissue Res 15:269–286
Raisz LG, Trummel CL, Holick MF, DeLuca HF (1972) 1,25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science 175:768–796
Raisz LG, Kream BE, Smith M, Simmons HA (1980) Comparison of the effect of vitamin D metabolites on collagen synthesis and resorption of fetal rat bone in organ culture. Calcif Tissue Int 32:135–138
Holtrop ME, Cox KA, Clark MB, Holick MF, Anast CS (1981) 1,25-Dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology 108:2293–2301
Kream BM, Jose M, Yamada S, DeLuca MF (1977) A specific high affinity-binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone. Science 197:1086–1088
Chen TL, Hirst MA, Feldman D (1979) A receptor-like binding macromolecule for 1α,25-dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem 254:7491–7494
Stumpf WE, Madhabanada S, DeLuca HF (1981) In: Cohn DV, Talmadge RV, Mathews JL (eds) Sites of action of 1,25(OH)2 vitamin D3 identified by thaw-mount autoradiography. Hormonal control of calcium metabolism. Excerpta Medica, Amsterdam, pp 222–229
Bar-Shavit Z, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J, Kahn AJ (1983) Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 80:5907–5911
Monolagas SC, Burton DW, Deftos LJ (1981) 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256:7116–7117
Rodan GA, Rodan SB (1984) Expression of the osteoblastic phenotype. In: Peck WA (ed) Bone and Mineral Research. Elsevier, New York, pp 244–285
Price PA, Baukol SA (1980) 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem 255:11660–11663
Price PA, Baukol SA (1981) 1,25-Dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone-dependent protein. Biochem Biophys Res Commun 99:928–935
Beresford JN, Gallagher JA, Poser JW, Russell RGG (1984) Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24.25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res 5:229–234
Howard GA, Bottemiller BL, Turner RT, Rader JI, Baylink DJ (1981) Parathyroid hormone stimulates bone formation and resorption in organ cultures: evidence for a coupling mechanism. Proc Natl Acad Sci (USA) 78:3204–3208
Drivdahl RH, Howard GA, Baylink DJ (1982) Extracts of bone contain a potent regulator of bone formation. Biochem Biophys Acta 714:26–36.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vandersteenhoven, J.J., DeLustro, F.A., Bell, N.H. et al. Osteoinduction by implants of demineralized allogeneic bone matrix is diminished in vitamin D-deficient rats. Calcif Tissue Int 42, 39–45 (1988). https://doi.org/10.1007/BF02555837
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02555837